|
|
Post by mnkdfann on May 28, 2019 20:25:20 GMT -5
You employ the word "natural" as if say any perturbation of this so-called natural order is inimical to mankind. Isn't government control a monopoly or tantamount to it? Why do you think, if you do, that central planning by so-called experts will work far better than any invisible hand? Your presupposition is that's private actors are not to be trusted and that they must be run roughshod over for some reason, which you don't specify. California badly mismanaged privatization and they are now a one-party state that is failing miserably. Look instead to Texas, where I enjoy a great deal of choice in my electricity provider and my bill is 1/4 of what it was in Connecticut, with similar loads, where there was no real choice whatsoever. FWIW: A number of Texas energy producers benefit from so-called 'clean coal' subsidies (i.e. government handouts). And Connecticut has some of the highest electricity charges, in part, due to deregulation. www.myrecordjournal.com/News/State/Experts-explain-Connecticut-s-high-electric-rates.html |
|
|
|
Post by mnkdfann on May 28, 2019 19:48:50 GMT -5
Looking at the MNKD share price graph starting circa October 2017, it appears MNKD more or less hits or drops below the previous 5-month cycle's low about every 5 months. This would be the 5th such cycle.
|
|
|
|
Post by mnkdfann on May 28, 2019 18:52:16 GMT -5
peppy - This may be a little off topic but, in martial arts they thought us to breathe to our stomach and not to the lungs. I'm sure air got to the lungs but the mass of air went to the stomach. Would air get to the blood vessels doing this? I am not kidding on this ... and we were definitely stronger using this method. But, that's mytakeonit The same is true for just prior to public speaking. I wondered whether that is really true, or a popular misconception? Something people get told to guide them, but not really true. Here we go: www.inpursuitofyoga.com/blog/2015/3/11/chest-breath-vs-belly-breathSummary: It appears you really aren't breathing the air into your belly, it is more of a state of mind (and the way you control your muscles). |
|
|
|
Post by mnkdfann on May 28, 2019 13:17:37 GMT -5
I suspect someone must have posted this oldish news before, but if so I couldn't find it. "FDA clears subcutaneous delivery system for United's Remodulin" "United Therapeutics (UTHR -1.6%) and development partner DEKA Research & Development Corp. announce FDA 510(k) clearance of the Unity Subcutaneous Delivery System for Remodulin (treprostinil), branded as the RemUnity system." seekingalpha.com/news/3459903-fda-clears-subcutaneous-delivery-system-uniteds-remodulin |
|
|
|
Post by mnkdfann on May 26, 2019 18:22:24 GMT -5
I watched from beginning to end. Could never get a focus on the fin. The pit stops focused on the popular names and leaders. Oh well. It was an exciting race regardless. I'm amazed how people are missing the point and opportunity...it doesn't end with the race, Conor is young and has a bright future ahead of him, just like Afrezza does...he will make an outstanding spokesperson for it going forward and "the mileage" Mannkind will get from the sponsorship will/should carry on well past the race. From what I remember Boca saying Rose told her, the cost wasn't as much as most would think and the marketing edge from this should be well worth it in the end whether with MNKD corp. or one with deeper pockets that can take advantage of it moving forward. The Andretti team taking him on was because they recognized his potential and it showed their insight very well in this race. He was in the top 5 until the crash with 20 laps to go, had already done his last pit stop and was within striking distance until the red flag...I would have loved to see where he would have finished without the crash. IMO this was a huge win for Mannkind Diabetes/Afrezza to be associated with Conor and his use of it. Andretti only took him on for this particular race, because Andretti's major sponsor (the Air Force) needed someone for the INDY 500 and (IIRC) the AF had sponsored him before. Sure, Andretti might use him again, but no guarantees at this point. Also, the Mannkind deal described in the press release seems to be for just the Indy 500. Which makes sense, considering Conor is without main sponsorship and may not race again this season (unless he can attract someone else's big pocket). But we can all hope for the best. |
|
|
|
Post by mnkdfann on May 26, 2019 16:25:31 GMT -5
Already a huge congratulations to both type 1 Indy Drivers!!!!! Agreed, but I believe Fiasp is out of the race and "never really in contention" 😉 Wait, what, Fiasp was out before Afrezza???  for those who otherwise won't get the joke. |
|
|
|
Post by mnkdfann on May 26, 2019 15:45:50 GMT -5
At least Mike knew enough not to post his selfie with Conor anywhere we'd likely see it.
|
|
|
|
Post by mnkdfann on May 26, 2019 13:15:01 GMT -5
Whatever happened, it was short lived. Maybe a leader-board glitch? He's back out and down to 11th.
|
|
|
|
Post by mnkdfann on May 26, 2019 13:12:07 GMT -5
And now he's in the pit again? I thought he just pitted a few laps ago.
|
|
|
|
Post by mnkdfann on May 26, 2019 13:10:23 GMT -5
Up to third just now. He's on fire.
|
|
|
|
Post by mnkdfann on May 26, 2019 12:57:09 GMT -5
Sorry but why is FIASP allowed to be placed on a fire suit but Afrezza is not allowed to be placed on a wing? Because Mannkind didn't ask for Afrezza to go on the wing? I am pretty sure that a product name alone counts as a reminder advert. Under FDA rules those don't require disclosure statements, but reminder adverts are limited to the drug name and it's generic name with no product claims. No risk disclosure required, so long as the reminder ad is allowed in the first place. www.fda.gov/drugs/resourcesforyou/consumers/prescriptiondrugadvertising/ucm072077.htmReminder Advertisements Reminder ads give the name of a drug, but not the drug's uses. These ads assume that the audience already knows the drug's use. A reminder ad does not have to contain risk information about the drug because the ad does not say what the drug does or how well it works. Unlike product claim ads, reminder ads cannot suggest, in either words or pictures, anything about the drug's benefits or risks. For example, a reminder ad for a drug that helps treat asthma should not include a drawing of a pair of lungs, because this implies what the drug does. Reminder ads are not allowed for certain prescription drugs with serious risks. Drugs with serious risks have a special warning, often called a "boxed warning," in the drug's FDA-approved prescribing information. Because of their seriousness, the risks must be included in all ads for these drugs.Read more: mnkd.proboards.com/thread/11190/indy-500-puts-face-afrezza?page=14#ixzz5p3SQ7KEJ |
|
|
|
Post by mnkdfann on May 26, 2019 9:03:28 GMT -5
Race day! Hamilton is currently leading in Monaco. Why didn't Mannkind sponsor an F1 car for that race? Perhaps one day.
|
|
|
|
Post by mnkdfann on May 25, 2019 18:19:18 GMT -5
Do sales reps know the identities of individual patients? When someone fills a prescription, does the pharma actually get the patient's name? I imagined this information would be protected. Yes they do. Me......@bhr01 laborer75 They aren’t titrating right or dosing correctly, it’s different when you have a MNKD long for a dad and you’re taking the drug. Or you went to Vdex and used their protocol. People get on it and get off it because they have don’t have guidance and the doctors aren’t informed. laborer.......@rooksleanne @bhr01 That's 100% accurate. My kid was supposed to meet up with Mannkind rep and his doctor to learn the correct way to use it. The rep finally called the house a week AFTER my kid was already using it. When the rep was told he was already using it, that rep didn't feel it important to meet up with him and his doctor. That rep missed a great opportunity to inform my son's doctor. This was the old Chicago rep. The new one must be just as shitty though judging by script numbers and retention rate. Management does not have this staff trained properly. Shit is all mixed up over there! If a doctor contacts a rep to work with a patient, or a rep contacts a doctor to offer assistance with any patients having trouble, or a patient contacts a doctor and asks the doc to set up a meeting with a rep, or a patient contacts a rep and asks they both meet with the doctor, those are all special cases. In all of those I can see how a rep would learn the patient's identity. I don't know the details of laborer's situation. Could it be one of those? But if a random patient fills a prescription does the pharmacy really relay that information to the local rep? Or do doctors automatically inform reps every time they prescribe that rep's product? Those are the cases I was wondering about. |
|
|
|
Post by mnkdfann on May 25, 2019 16:29:22 GMT -5
Instead of wasting 9 million on a very confusing tv ad why not have our sales reps reach out to each new patient and make sure they know how to dose Af. and help them with insurance problems. Do sales reps know the identities of individual patients? When someone fills a prescription, does the pharma actually get the patient's name? I imagined this information would be protected. |
|
|
|
Post by mnkdfann on May 24, 2019 14:15:46 GMT -5
Are you on Facebook? Have you ever clicked through to a post relating to diabetes on someone like Conor Daly's or Laura Cronen's feed? They track all your interactions with those platforms. I do not have a Facebook account, it's been deactivated for years. My Instagram account doesn't have a single connection to diabetes. I've never even searched for anything related to diabetes on my Instagram account either. They have a myriad of ways to capture your interests. For instance, from sites you visit, posts you like, apps you use, key words in Messenger conversations. |
|
for those who otherwise won't get the joke.
